Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation

被引：0
|
作者：
Diekmann, F [1 ]
Waiser, J [1 ]
Einecke, G [1 ]
Dragun, D [1 ]
Fritsche, L [1 ]
Neumayer, HH [1 ]
Budde, K [1 ]
机构：
[1] Charite, Berlin, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364A / 364A
页数：1
相关论文
共 50 条
  • [31] PREDICTORS OF SUCCESSFUL (LATE) CONVERSION FROM CNI TO mTOR INHIBITOR SIROLIMUS (SRL) IN RENAL TANSPLANT RECIPIENTS
    Ramyasuda, Swaminathan
    Rajalingam, Sinnaih
    Ashley, Irish
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A2 - A3
  • [32] Sirolimus rescue treatment in calcineurin-inhibitor nephrotoxicity after kidney transplantation
    Wyzgal, J
    Paczek, L
    Senatorski, G
    Zygier, J
    Rowinski, W
    Szmidt, J
    Perkowska, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) : 3185 - 3187
  • [33] A 7-YEARS EXPERIENCE IN USING SIROLIMUS IN PAEDIATRIC RENAL TRANSPLANTATION WITH CNI TOXICITY
    Pak-Chiu, Tong
    Lai Wai-Ming
    Lap-Tak, Ma
    Tse Kei-Chiu
    TRANSPLANT INTERNATIONAL, 2013, 26 : 125 - 125
  • [34] Conversion to Sirolimus for Chronic Allograft Nephropathy and Calcineurin Inhibitor Toxicity and the Adverse Effects of Sirolimus After Conversion
    Sayin, B.
    Karakayali, H.
    Colak, T.
    Sevmis, S.
    Pehlivan, S.
    Demirhan, B.
    Haberal, M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2789 - 2793
  • [35] THE EFFECTS OF CONVERSION FROM CNI (CALCINUERIN INHIBITORS) TO SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Borman, Natalie L.
    Venkat-Raman, Gopalakrishnan
    TRANSPLANT INTERNATIONAL, 2009, 22 : 115 - 115
  • [36] Influence of CNI-free versus CNI-based immunosuppression on rejection and infection after heart transplantation
    Leet, A. S.
    Martin, R.
    Richardson, M.
    Bergin, P.
    Esmore, D.
    Kaye, D. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S227 - S228
  • [37] A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency
    Zuckermann, A.
    Keogh, A.
    Crespo-Leiro, M. G.
    Mancini, D.
    Gonzalez-Vilchez, F.
    Almenar, L.
    Brozena, S.
    Eisen, H.
    Tai, S. See
    Kashwaha, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S85 - S85
  • [38] THE EFFECT OF MTOR OR CNI BASED MAINTAINANCE IMMUNOSUPPRESSION ON MEASURED RENAL FUNCTION AFTER LIVER TRANSPLANTATION
    Schaffellner, Silvia
    Gutschi, Juergen
    Zitta, Sabine
    Meinitzer, Andreas
    Kniepeiss, Daniela
    Reibnegger, Gilbert
    Rosenkranz, Alexander R.
    Wagner, Doris
    TRANSPLANT INTERNATIONAL, 2013, 26 : 292 - 292
  • [39] CNI-free immunosuppression decreases the risk of malignancy after renal transplantation
    Matthews K.
    Nature Clinical Practice Nephrology, 2006, 2 (4): : 183 - 183
  • [40] Switch to sirolimus due to CNI associated toxicity after liver transplantation is safe and effective
    Thrum, Katharina
    Kuepper, Bernadett
    Baerthel, Erik
    Koch, Alexander
    Habrecht, Olaf
    Wilberg, Jens
    Settmacher, Utz
    Kornberg, Arno
    TRANSPLANT INTERNATIONAL, 2007, 20 : 128 - 128
12345